FUSED AMINO PYRIDINE AS HSP90 INHIBITORS

The present invention relates to HSP90 inhibitors containing fused amino pyridine core that are useful as inhibitors of HSP90 and their use in the treatment of HSP90 related diseases and disorders such as cancer, an autoimmune disease, or a neurodegenerative disease.

Saved in:
Bibliographic Details
Main Authors Qian Changgeng, Zhai Haixiao, Cai Xiong
Format Patent
LanguageEnglish
Published 05.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to HSP90 inhibitors containing fused amino pyridine core that are useful as inhibitors of HSP90 and their use in the treatment of HSP90 related diseases and disorders such as cancer, an autoimmune disease, or a neurodegenerative disease.
Bibliography:Application Number: US201615200232